IGF2BP1 and leukemia: Our previous study of leukemia stem cells (LSC) properties (e.g., tumorigenicity, clonogenicity, and expression of aldehyde dehydrogenase (ALDH) by ALDEFLUORTM analysis) established IGF2BP1 as an important regulator of the leukemia stem cell phenotype.